ESMO-Virtual-Preceptorship-Urothelial-2021-1000x250-November

Start date: 17 Nov 2021
End date: 18 Nov 2021
Location: Virtual, GMT +8

Learning objectives

To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder cancer
To understand essentials in the assessment and multidisciplinary treatment of bladder cancer
To learn about advances in treatment and novel targets in bladder cancer

Accreditation

The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Laurence Albiges, France
Ravindran Kanesvaran, Singapore